Eliglustat hemitartrate
CAS: 928659-70-5
Ref. 3D-DMB65970
| 1mg | 88.00 € | ||
| 2mg | 105.00 € | ||
| 5mg | 157.00 € | ||
| 10mg | 235.00 € | ||
| 25mg | 414.00 € |
Product Information
Eliglustat hemitartrate is a drug that inhibits the enzyme glucosylceramide synthase, which is involved in the production of glucosylceramide. Eliglustat hemitartrate is used to treat Gaucher disease, a rare genetic disorder where fatty substances accumulate in the liver and spleen. Eliglustat hemitartrate has been shown to reduce the levels of glucosylceramide in patients with Gaucher disease and may be an effective treatment for this condition. It also has been shown to inhibit P-glycoprotein (P-gp), which may allow more eliglustat to enter cells.
Chemical properties
Technical inquiry about: 3D-DMB65970 Eliglustat hemitartrate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
